Literature DB >> 22053072

Reperfusion injury intensifies the adaptive human T cell alloresponse in a human-mouse chimeric artery model.

Tai Yi1, Birgit Fogal, Zhengrong Hao, Zuzana Tobiasova, Chen Wang, Deepak A Rao, Rafia S Al-Lamki, Nancy C Kirkiles-Smith, Sanjay Kulkarni, John R Bradley, Alfred L M Bothwell, William C Sessa, George Tellides, Jordan S Pober.   

Abstract

OBJECTIVE: Perioperative nonimmune injuries to an allograft can decrease graft survival. We have developed a model for studying this process using human materials. METHODS AND
RESULTS: Human artery segments were transplanted as infrarenal aortic interposition grafts into an immunodeficient mouse host, allowed to "heal in" for 30 days, and then retransplanted into a second mouse host. To induce a reperfusion injury, the healed-in artery segments were incubated for 3 hours under hypoxic conditions ex vivo before retransplantation. To induce immunologic rejection, the animals receiving the retransplanted artery segment were adoptively transferred with human peripheral blood mononuclear cells or purified T cells from a donor allogeneic to the artery 1 week before surgery. To compare rejection of injured versus healthy tissues, these manipulations were combined. Results were analyzed ex vivo by histology, morphometry, immunohistochemistry, and mRNA quantitation or in vivo by ultrasound. Our results showed that reperfusion injury, which otherwise heals with minimal sequelae, intensifies the degree of allogeneic T cell-mediated injury to human artery segments.
CONCLUSIONS: We developed a new human-mouse chimeric model demonstrating interactions of reperfusion injury and alloimmunity using human cells and tissues that may be adapted to study other forms of nonimmune injury and other types of adaptive immune responses.

Entities:  

Mesh:

Year:  2011        PMID: 22053072      PMCID: PMC3262100          DOI: 10.1161/ATVBAHA.111.239285

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  32 in total

Review 1.  Chronic rejection.

Authors:  P Libby; J S Pober
Journal:  Immunity       Date:  2001-04       Impact factor: 31.745

2.  Human vascular smooth muscle cells lack essential costimulatory molecules to activate allogeneic memory T cells.

Authors:  Pei Zhang; Thomas D Manes; Jordan S Pober; George Tellides
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-06-10       Impact factor: 8.311

3.  Vascular endothelium does not activate CD4+ direct allorecognition in graft rejection.

Authors:  Daniel Kreisel; Alyssa M Krasinskas; Alexander S Krupnick; Andrew E Gelman; Keki R Balsara; Sicco H Popma; Markus Riha; Ariella M Rosengard; Laurence A Turka; Bruce R Rosengard
Journal:  J Immunol       Date:  2004-09-01       Impact factor: 5.422

4.  Ultrastructural alterations during ischemia and reperfusion in human hearts during cardiac surgery.

Authors:  J Schaper; F Hehrlein; M Schlepper; K U Thiedemann
Journal:  J Mol Cell Cardiol       Date:  1977-03       Impact factor: 5.000

5.  Association of thrombospondin-1 and cardiac allograft vasculopathy in human cardiac allografts.

Authors:  X M Zhao; Y Hu; G G Miller; R N Mitchell; P Libby
Journal:  Circulation       Date:  2001-01-30       Impact factor: 29.690

6.  Interferon-gamma elicits arteriosclerosis in the absence of leukocytes.

Authors:  G Tellides; D A Tereb; N C Kirkiles-Smith; R W Kim; J H Wilson; J S Schechner; M I Lorber; J S Pober
Journal:  Nature       Date:  2000-01-13       Impact factor: 49.962

7.  Interferon-gamma plays a nonredundant role in mediating T cell-dependent outward vascular remodeling of allogeneic human coronary arteries.

Authors:  Yinong Wang; William R Burns; Paul C Y Tang; Tai Yi; Jeffrey S Schechner; Hans-Guenter Zerwes; William C Sessa; Marc I Lorber; Jordan S Pober; George Tellides
Journal:  FASEB J       Date:  2004-01-20       Impact factor: 5.191

8.  Cold ischemia and the reduced long-term survival of cadaveric renal allografts.

Authors:  Abdulla K Salahudeen; Naeem Haider; Warren May
Journal:  Kidney Int       Date:  2004-02       Impact factor: 10.612

9.  The allograft defines the type of rejection (acute versus chronic) in the face of an established effector immune response.

Authors:  Geetha Chalasani; Qi Li; Bogumila T Konieczny; Lonnette Smith-Diggs; Barbara Wrobel; Zhenhua Dai; David L Perkins; Fady K Baddoura; Fadi G Lakkis
Journal:  J Immunol       Date:  2004-06-15       Impact factor: 5.422

10.  Heterologous immunity provides a potent barrier to transplantation tolerance.

Authors:  Andrew B Adams; Matthew A Williams; Thomas R Jones; Nozomu Shirasugi; Megan M Durham; Susan M Kaech; E John Wherry; Thandi Onami; J Gibson Lanier; Kenneth E Kokko; Thomas C Pearson; Rafi Ahmed; Christian P Larsen
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808

View more
  17 in total

1.  Blocking MHC class II on human endothelium mitigates acute rejection.

Authors:  Parwiz Abrahimi; Lingfeng Qin; William G Chang; Alfred L M Bothwell; George Tellides; W Mark Saltzman; Jordan S Pober
Journal:  JCI Insight       Date:  2016-01-21

2.  Complement C5 Inhibition Reduces T Cell-Mediated Allograft Vasculopathy Caused by Both Alloantibody and Ischemia Reperfusion Injury in Humanized Mice.

Authors:  L Qin; G Li; N Kirkiles-Smith; P Clark; C Fang; Y Wang; Z-X Yu; D Devore; G Tellides; J S Pober; D Jane-Wit
Journal:  Am J Transplant       Date:  2016-06-14       Impact factor: 8.086

Review 3.  Aging and the immune response to organ transplantation.

Authors:  Monica M Colvin; Candice A Smith; Stefan G Tullius; Daniel R Goldstein
Journal:  J Clin Invest       Date:  2017-05-15       Impact factor: 14.808

Review 4.  Processes of sterile inflammation.

Authors:  Hua Shen; Daniel Kreisel; Daniel Robert Goldstein
Journal:  J Immunol       Date:  2013-09-15       Impact factor: 5.422

5.  Nanoparticle targeting to the endothelium during normothermic machine perfusion of human kidneys.

Authors:  Gregory T Tietjen; Sarah A Hosgood; Jenna DiRito; Jiajia Cui; Deeksha Deep; Eric Song; Jan R Kraehling; Alexandra S Piotrowski-Daspit; Nancy C Kirkiles-Smith; Rafia Al-Lamki; Sathia Thiru; J Andrew Bradley; Kourosh Saeb-Parsy; John R Bradley; Michael L Nicholson; W Mark Saltzman; Jordan S Pober
Journal:  Sci Transl Med       Date:  2017-11-29       Impact factor: 17.956

6.  Endothelial Cell-Derived Interleukin-18 Released During Ischemia Reperfusion Injury Selectively Expands T Peripheral Helper Cells to Promote Alloantibody Production.

Authors:  Lufang Liu; Caodi Fang; Whitney Fu; Bo Jiang; Guangxin Li; Lingfeng Qin; Jacob Rosenbluth; Gavin Gong; Catherine B Xie; Peter Yoo; George Tellides; Jordan S Pober; Dan Jane-Wit
Journal:  Circulation       Date:  2019-11-20       Impact factor: 29.690

Review 7.  Interacting mechanisms in the pathogenesis of cardiac allograft vasculopathy.

Authors:  Jordan S Pober; Dan Jane-wit; Lingfeng Qin; George Tellides
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-06-05       Impact factor: 8.311

8.  Rapamycin-treated human endothelial cells preferentially activate allogeneic regulatory T cells.

Authors:  Chen Wang; Tai Yi; Lingfeng Qin; Roberto A Maldonado; Ulrich H von Andrian; Sanjay Kulkarni; George Tellides; Jordan S Pober
Journal:  J Clin Invest       Date:  2013-03-08       Impact factor: 14.808

Review 9.  Inflammatory triggers of acute rejection of organ allografts.

Authors:  Daniel N Mori; Daniel Kreisel; James N Fullerton; Derek W Gilroy; Daniel R Goldstein
Journal:  Immunol Rev       Date:  2014-03       Impact factor: 12.988

10.  Noninvasive detection of lipids in atherosclerotic plaque using ultrasound thermal strain imaging: in vivo animal study.

Authors:  Ahmed M Mahmoud; Debaditya Dutta; Linda Lavery; Douglas N Stephens; Flordeliza S Villanueva; Kang Kim
Journal:  J Am Coll Cardiol       Date:  2013-07-31       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.